Tag: pfizer
July 22, 2018
5 Top Weekly NASDAQ Biotech Stocks: MiMedx Group Leads
MiMedx Group, Avid Bioservices, Lifevantage, EyePoint Pharmaceuticals and BioLife Solutions were last week's top gainers on the NASDAQ Biotechnology Index.
July 16, 2018
What Is In-Licensing?
Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions. Read on... July 15, 2018
5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top
Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ... July 1, 2018
5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top
Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index. June 29, 2018
XELJANZ (tofacitinib citrate) Receives Marketing Authorisation in the European Union for Active Psoriatic Arthritis
Pfizer (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ (tofacitinib citrate) 5 mg twice daily (BID) in combination...
June 28, 2018
5 Top NASDAQ Genetic Stocks Year-to-Date
In the final days of Q2 2018, we've profiled the five top NASDAQ genetic stocks year-to-date. Here's a look at... June 27, 2018
U.S. FDA Grants Priority Review for Pfizer’s New Drug Application for Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia
Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted the company’s New Drug Application and granted... June 25, 2018
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE in HR+, HER2- Metastatic Breast Cancer
Pfizer (NYSE:PFE) today announced overall survival (OS) results from the Phase 3 PALOMA-3 trial, which evaluated IBRANCE® (palbociclib) in combination with...
June 19, 2018
Myriad Receives FDA SPMA Approval for BRACAnalysis CDx
Once approved, BRACAnalysis CDx will be used with Pfizer's PARB inhibitor, talazoparib. Talazoparib has a prescription drug user fee act... June 10, 2018